These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 2190306)

  • 1. Why do ulcers heal with sucralfate?
    Lam SK
    Scand J Gastroenterol Suppl; 1990; 173():6-16. PubMed ID: 2190306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of sucralfate-induced ulcer healing and relapse.
    Lam SK
    Am J Med; 1989 Jun; 86(6A):122-6. PubMed ID: 2660554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of duodenal ulcer with sucralfate.
    Lam SK
    Scand J Gastroenterol Suppl; 1991; 185():22-8. PubMed ID: 1683491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosa protectives: sucralfate and colloidal bismuth subcitrate in peptic ulcer disease.
    Tytgat GN; Nio CY
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():152-61. PubMed ID: 3660894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sucralfate overcomes adverse effect of cigarette smoking on duodenal ulcer healing and prolongs subsequent remission.
    Lam SK; Hui WM; Lau WY; Branicki FJ; Lai CL; Lok AS; Ng MM; Fok PJ; Poon GP; Choi TK
    Gastroenterology; 1987 May; 92(5 Pt 1):1193-201. PubMed ID: 3557014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical therapy of peptic ulcer disease.
    McQuaid KR; Isenberg JI
    Surg Clin North Am; 1992 Apr; 72(2):285-316. PubMed ID: 1347960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sucralfate: the Bangkok review.
    Korman MG; Bolin TD; Szabo S; Hunt RH; Marks IN; Glise H
    J Gastroenterol Hepatol; 1994; 9(4):412-5. PubMed ID: 7948825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
    Dajani EZ; Agrawal NM
    Dig Dis; 1995 Jan; 13 Suppl 1():48-61. PubMed ID: 7697902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoprotective and ulcer healing properties of prostaglandin E2, colloidal bismuth and sucralfate in rats.
    Konturek SJ; Stachura J; Radecki T; Drozdowicz D; Brzozowski T
    Digestion; 1987; 38(2):103-13. PubMed ID: 3126091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sucralfate and other non-antisecretory agents in the treatment of peptic ulcer disease.
    May B
    Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():113-6. PubMed ID: 2657280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antisecretory and mucosa-protecting drugs in the acute care of peptic ulcer. Review of action principles, healing rates and side effects of approved ulcer drugs and drugs under clinical trial].
    Simon B; Müller P; Dammann HG
    Fortschr Med; 1984 Jul; 102(25-26):683-7. PubMed ID: 6147304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ulcer recurrences following initial ulcer healing with sucralfate or cimetidine.
    Solhaug JH; Carling L; Glise H; Hallerbäck B; Hallgren T; Kagevi I; Svedberg LE; Wählby L
    Scand J Gastroenterol Suppl; 1987; 127():77-80. PubMed ID: 3475770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative dynamic study of the effectiveness of gastric cytoprotection by vitamin A, De-Nol, sucralfate and ulcer healing by pirenzepine in patients with chronic gastric ulcer (a multiclinical and randomized study).
    Patty I; Tárnok F; Simon L; Jávor T; Deák G; Benedek S; Kenéz P; Nagy L; Mózsik G
    Acta Physiol Hung; 1984; 64(3-4):379-84. PubMed ID: 6397969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ulcer healing and relapse rates after initial treatment with cimetidine or sucralfate.
    Marks IN; Lucke W; Wright JP; Girdwood AH
    J Clin Gastroenterol; 1981; 3(Suppl 2):163-5. PubMed ID: 7033353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of food and antacid on binding of sucralfate to normal and ulcerated gastric and duodenal mucosa in rats.
    Giesing DH; Bighley LD; Iles RL
    J Clin Gastroenterol; 1981; 3(Suppl 2):111-6. PubMed ID: 6895642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs for treatment of peptic ulcers.
    Dajani EZ; Trotman BW
    J Assoc Acad Minor Phys; 1992; 3(3):78-88. PubMed ID: 1353999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cigarette smoking on duodenal ulcer healing and relapse rate.
    Boonyapisit S; Manatsathit S; Kachintorn U; Tanwandee T; Sattawatthamrong Y; Chinapak O
    J Med Assoc Thai; 1994 Nov; 77(11):566-71. PubMed ID: 7759964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapse rate of healed duodenal, prepyloric, and gastric ulcers treated either with sucralfate or cimetidine.
    Glise H; Carling L; Hallerbaeck B; Hallgren T; Kagevi I; Solhaug JH; Svedberg LE; Waehlby L
    Am J Med; 1987 Sep; 83(3B):105-9. PubMed ID: 3310625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors.
    Lazzaroni M; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S73-8. PubMed ID: 10379473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoprotective agents and ulcer relapse.
    McLean AJ; McCarthy P; Dudley FJ
    Med J Aust; 1985 Feb; 142(3):S25-8. PubMed ID: 3838199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.